Investing.comCodex · 实盘不做把握 6/10不做原因:无增量信息
北京时间·🕒 发布 19:08:52·⟳ 抓取 19:10:00 +1m08s·⚡ 决策 09-02 19:38:47 +28m47s·55.0 天前
Aurora Cannabis 董事会正式建议股东拒绝 Curaleaf 敌意收购要约
本次是已公开敌意收购过程中的正式董事通函，强化 Aurora 反对立场但没有新增报价、白衣骑士、监管进展或股东投票结果；对 ACB.US 和 CURLF.US 都缺少可执行的明确正期望。
📄 原文Investing.com↗ 原文
Aurora Cannabis urges shareholders to reject Curaleaf bid
Oil prices rise for third session as US-Iran tensions fuel supply concerns EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB…
不做 Aurora Cannabis Inc.（ACB.US）
董事会正式拒绝属于已知敌意收购流程推进，未新增提价、竞购方或股东支持证据；方向在提价可能和交易失败风险之间摇摆。
不做 Curaleaf Holdings, Inc.（CURLF.US）
Aurora 拒绝提高交易阻力，但不是 Curaleaf 经营或财务层面的强空催化，且后续可能通过提价或谈判修复。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Curaleaf 的敌意要约和 Aurora 的反对态度已在 2026-08-11、2026-08-18/19 和 2026-08-24 多轮披露；2026-09-02 的新闻主要是董事通函正式建议拒绝，增量为公平性意见和投票权/现金债务论证。它可能提高 Aurora 争取更高报价的叙事，但也提高交易失败概率，方向不够单边，且当前美国市场仍盘前不可成交，因此不做。
消息传播链
- Aurora 首次公开回应 Curaleaf 收购意向，称提案未经邀约且细节不足，董事会成立特别委员会评估。
- Curaleaf 正式发起要约，披露每股 0.3463 股 Curaleaf 加 0.75 美元现金、隐含 4.00 美元对价。
- Aurora 要求股东暂不行动，称 Curaleaf 试图低价收购其 EU-GMP 设施和全球医用大麻平台。
- Aurora 再次反驳 Curaleaf 对业务表现的说法，并提示正式董事建议尚待发布。
- Investing.com 报道 Aurora 已提交董事通函并正式建议股东拒绝 Curaleaf 要约。市场反应:页面显示报道时 ACB -0.53%、CURA +1.94%，但未作为可交易报价使用。
关键理由
- Aurora 正式拒绝可能迫使 Curaleaf 提价，但该逻辑已在前期公开攻防中被市场部分预期。
- Curaleaf 换股加现金要约的治理和债务争议削弱交易确定性，不能直接转化为 Aurora 可执行多头。
主要风险
- Curaleaf 若迅速提高报价，ACB.US 可能跳空重定价，当前 AVOID 会错过事件套利机会。
- 若 Curaleaf 撤回要约，Aurora 的收购溢价可能回吐。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-08-24 · 影响 weakens
Curaleaf 反称 Aurora 经营表现和指引较弱，认为其报价提供溢价和更大平台上行，削弱 Aurora 独立价值叙事的确定性。
检索:Aurora Cannabis Curaleaf bid undervalues no debt Curaleaf debt voting rights counter evidence 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-09-02 · 影响 none
Aurora 称 Curaleaf 债务和租赁负债超过 10 亿美元且多重投票结构不利，但这是交易攻防材料，不足以构成 Curaleaf 的明确强空催化。
检索:Curaleaf Aurora takeover bid rejection financing debt liabilities risk 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例降低对 ACB.US 直接追多的信心，并支持等待新报价或交易失败确认。
方向:低相似先例只说明董事会拒绝会提高谈判不确定性，不能稳定指向做多或做空。
涨幅量级:没有 8 分以上同市场同机制先例，不能据此设定幅度。
形态:可见风险是收购预期若消退会回吐，但本次尚未发生撤回或提价。
历史先例(按相似度)
- 相似度 5/10 EBAY 2026-05-12 eBay 董事会拒绝 GameStop 非邀约、非约束性收购提案。 原文 ↗
事件后 +1日 +2.1% · +2日 +4.5% · +3日 +4.7% · +4日 +7.4% · +5日 +5.8%
相似度依据:同为上市公司董事会拒绝非邀约收购，但行业、交易规模和收购方可信度不同。
经验:董事会拒绝本身通常只确认谈判分歧，价格反应更取决于提价概率和要约可信度。 - 相似度 4/10 PYPL 2026-08-29 媒体报道 Advent 和 Stripe 放弃 PayPal 收购方案，PayPal 股价大跌。 原文 ↗
事件后 +1日 -1.9% · +2日 -2.4%
⚠非首发(转载/聚合)·来源层级不符(声明media/实为aggregator)·锚前1-2日已异动13.2%>锚定日1.9% — 该行涨幅别用来定止盈止损
相似度依据:同属收购预期消退案例，但该事件是潜在买方放弃而非目标董事会拒绝。
经验:当收购预期被撤销，前期由交易预期支撑的股价可能快速回吐。
工具执行结果 · 成功 4 · 降级 0 · 失败 0 · 取消 0
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
原文全文
展开原文 · 1,969 字
Oil prices rise for third session as US-Iran tensions fuel supply concerns
EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB) (NASDAQ:ACB) filed a directors’ circular today recommending shareholders reject the unsolicited takeover bid from Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF), according to a press release statement.
Aurora’s board of directors unanimously concluded the bid is not in the best interests of the company or its shareholders following a review by a special committee of independent directors and consultation with financial and legal advisors.
Aurora holds $149 million in cash and restricted cash as of June 30, 2026, and carries no debt. Curaleaf has over $1 billion in debt and lease liabilities as of the same date, according to financial statements filed by both companies on August 5, 2026.
Under the proposed transaction, Aurora shareholders would receive Curaleaf shares in exchange for their holdings. Based on the exchange ratio, Aurora shareholders would own approximately 7.7% of the combined company but hold only approximately 3.2% of voting rights due to Curaleaf’s multi-voting share structure.
"Curaleaf is not offering you fair value for your shares, and your cash, your rights and your future upside are at stake," said Miguel Martin, executive chairman and CEO of Aurora.
The board’s financial advisor provided a written opinion dated September 1, 2026, which is included in the circular.
TD Securities Inc. stated in August 2026 that the bid undervalues Aurora and does not adequately reflect its medical cannabis leadership, balance sheet flexibility, international expertise, or long-term growth potential.
Aurora shareholders who have tendered shares can withdraw them by contacting their broker or Kingsdale Advisors. The company directed shareholders to take no action and not tender their shares to the offer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
EDMONTON, AB - Aurora Cannabis Inc. (TSX:ACB) (NASDAQ:ACB) filed a directors’ circular today recommending shareholders reject the unsolicited takeover bid from Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF), according to a press release statement.
Aurora’s board of directors unanimously concluded the bid is not in the best interests of the company or its shareholders following a review by a special committee of independent directors and consultation with financial and legal advisors.
Aurora holds $149 million in cash and restricted cash as of June 30, 2026, and carries no debt. Curaleaf has over $1 billion in debt and lease liabilities as of the same date, according to financial statements filed by both companies on August 5, 2026.
Under the proposed transaction, Aurora shareholders would receive Curaleaf shares in exchange for their holdings. Based on the exchange ratio, Aurora shareholders would own approximately 7.7% of the combined company but hold only approximately 3.2% of voting rights due to Curaleaf’s multi-voting share structure.
"Curaleaf is not offering you fair value for your shares, and your cash, your rights and your future upside are at stake," said Miguel Martin, executive chairman and CEO of Aurora.
The board’s financial advisor provided a written opinion dated September 1, 2026, which is included in the circular.
TD Securities Inc. stated in August 2026 that the bid undervalues Aurora and does not adequately reflect its medical cannabis leadership, balance sheet flexibility, international expertise, or long-term growth potential.
Aurora shareholders who have tendered shares can withdraw them by contacting their broker or Kingsdale Advisors. The company directed shareholders to take no action and not tender their shares to the offer.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。